Regina Engel Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

10/2008

In vitro and in vivo characterization of a Mycobacterium tuberculosis mutant deficient in glycosyltransferase Rv1500.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Regina Engel Research Topics

Disease

3	Infections 01/2017 - 10/2008
2	Tuberculosis (Tuberculoses) 01/2017 - 10/2008
1	Hypersensitivity (Allergy) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Respiratory Sounds (Crackle) 05/2004

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	GlycolipidsIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	AntigensIBA 01/2019
1	LipidsIBA 01/2019
1	PentosesIBA 01/2017
1	Interleukin-12 Subunit p40IBA 10/2008
1	lipoarabinomannan (LAM)IBA 10/2008
1	lipomannanIBA 10/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2008
1	GlycosyltransferasesIBA 10/2008
1	phosphatidylinositol mannosideIBA 10/2008
1	Muramic Acids (Muramic Acid)IBA 05/2004
1	EndotoxinsIBA 05/2004

Therapy/Procedure

1	Therapeutics 01/2017